Skip to content
Healthcare
KZActiveBIN 180542006914
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ПРЕДСТАВИТЕЛЬСТВО РГП на ПХВ "РЕСПУБЛИКАНСКИЙ ЦЕНТР ПО КООРДИНАЦИИ ТРАНСПЛАНТАЦИИ И ВЫСОКОТЕХНОЛОГИЧНЫХ МЕДИЦИНСКИХ УСЛУГ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РК В ГОРОДЕ АСТАНА

Director
Абраева Сауле Болатовна
Incorporated
05.05.2018
Address
Астана пр. РАҚЫМЖАН ҚОШҚАРБАЕВ, зд. 66
РНН
620200595709

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ПРЕДСТАВИТЕЛЬСТВО РЕСПУБЛИКАНСКОГО ГОСУДАРСТВЕННОГО ПРЕДПРИЯТИЯ НА ПРАВЕ ХОЗЯЙСТВЕННОГО ВЕДЕНИЯ "РЕСПУБЛИКАНСКИЙ ЦЕНТР ПО КООРДИНАЦИИ ТРАНСПЛАНТАЦИИ И ВЫСОКОТЕХНОЛОГИЧНЫХ МЕДИЦИНСКИХ УСЛУГ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ КАЗАХСТАН В ГОРОДЕ АСТАНА
BIN
180542006914
Status
Active
Director
Абраева Сауле Болатовна
Registration date
05.05.2018
Activity
Общая врачебная практика
Legal address
Астана пр. РАҚЫМЖАН ҚОШҚАРБАЕВ, зд. 66
VAT payer
No
КАТО
711110000
РНН
620200595709
КФС
Республиканская собственность
КСЕ
Государственные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 6 до 10 чел.

Has changed

Activities

1
86210primary

Общая врачебная практика

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
730.1K
2025
1.3M+121%
2024
597.4K+174%
2023
218K-58%
2022
521.9K+221%
2021
162.6K
·730.1K
2026year to date
+121%1.3M
2025
+174%597.4K
2024
-58%218K
2023
+221%521.9K
2022
·162.6K
2021
2026
Tax paid730,100 ₸
Penalty20,000 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid1,321,198 ₸
Penalty5,000 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid597,411 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid218,000 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid521,940 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid162,600 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • АС

    Абраева Сауле Болатовна

    Director

Former directors

  • ЖБЖАРКИМБЕКОВ БАКЫТ КАЛЖЕШОВИЧ
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ПРЕДСТАВИТЕЛЬСТВО РГП на ПХВ "РЕСПУБЛИКАНСКИЙ ЦЕНТР ПО КООРДИНАЦИИ ТРАНСПЛАНТАЦИИ И ВЫСОКОТЕХНОЛОГИЧНЫХ МЕДИЦИНСКИХ УСЛУГ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РК В ГОРОДЕ АСТАНА (BIN 180542006914) is an active legal entity in Астана, registered in 2018 (8 years on the market). Primary activity — общая врачебная практика. Automated screening of open registries found no risk indicators for "РЕСПУБЛИКАНСКИЙ ЦЕНТР ПО КООРДИНАЦИИ ТРАНСПЛАНТАЦИИ И ВЫСОКОТЕХНОЛОГИЧНЫХ МЕДИЦИНСКИХ УСЛУГ". Director on record — Абраева Сауле Болатовна. Data current as of November 8, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.